Literature DB >> 1343086

A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development.

M Nakamoto1, S Matsubara, T Miyauchi, H Obama, M Ozawa, T Muramatsu.   

Abstract

MK (midkine) and HB-GAM (heparin-binding growth-associated molecule) constitute a new family of heparin-binding growth differentiation factors. The modes of expression of MK and HB-GAM during mouse development were quantitatively examined by mRNA hybridization. The following three distinct patterns of expression were observed in the brain/head region. On the 11th-13th days of gestation, MK was intensely, but HB-GAM relatively weakly expressed; on the 15th-19th days, both MK and HB-GAM expression became weaker; and in the neonatal period, HB-GAM was intensely expressed and MK expression increased slightly. The level of HB-GAM expression was lower than that of MK in the whole embryo on the 11th to 13th days of gestation. HB-GAM mRNA was detected in the kidney of newborn and young mice, where MK was more highly expressed. The identity of the weakly expressed MK and HB-GAM signals was confirmed by means of the polymerase chain reaction in the neonatal brain (MK), the head of 13-day embryos (HB-GAM), and the kidney of 7-day-old mice (HB-GAM). In conclusion, MK and HB-GAM are frequently co-expressed in the same cells and anatomic regions of the fetus or new born mouse, while their modes of expression differ.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1343086     DOI: 10.1093/oxfordjournals.jbchem.a123903

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

Review 1.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.

Authors:  Ruda Cui; Peter Lwigale
Journal:  Gene Expr Patterns       Date:  2019-02-27       Impact factor: 1.224

3.  Pleiotrophin Interaction with Synthetic Glycosaminoglycan Mimetics.

Authors:  Jonathan R Miles; Xu Wang; Jose L de Paz; Pedro M Nieto
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-19

4.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

Review 5.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS).

Authors:  Sara Tavella; Alessandra Ruggiu; Alessandra Giuliani; Francesco Brun; Barbara Canciani; Adrian Manescu; Katia Marozzi; Michele Cilli; Delfina Costa; Yi Liu; Federica Piccardi; Roberta Tasso; Giuliana Tromba; Franco Rustichelli; Ranieri Cancedda
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

7.  Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer.

Authors:  Youn Hee Jee; Samira M Sadowski; Francesco S Celi; Liqiang Xi; Mark Raffeld; David B Sacks; Alan T Remaley; Anton Wellstein; Electron Kebebew; Jeffrey Baron
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

8.  Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies.

Authors:  Youn Hee Jee; Yael Lebenthal; Piya Chaemsaithong; Gai Yan; Ivana Peran; Anton Wellstein; Roberto Romero; Jeffrey Baron
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

9.  Midkine's Role in Cardiac Pathology.

Authors:  Kathleen C Woulfe; Carmen C Sucharov
Journal:  J Cardiovasc Dev Dis       Date:  2017-08-24

Review 10.  Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury.

Authors:  Emily Ross-Munro; Faith Kwa; Jenny Kreiner; Madhavi Khore; Suzanne L Miller; Mary Tolcos; Bobbi Fleiss; David W Walker
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.